26
|
Dhaille F, Dillies A, Dessirier F, Reygagne P, Diouf M, Balthazard T, Lombart F, Hébert V, Chopinnaud M, Verneuil L, Becquart C, Delaporte E, Lok C, Chaby G. 单一典型的毛发镜检特征可预测头癣. Br J Dermatol 2019. [DOI: 10.1111/bjd.18507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
27
|
Chaby G, Maldini C, Haddad C, Lebrun‐Vignes B, Hemery F, Ingen‐Housz‐Oro S, Gonzalez‐Chiappe S, Wolkenstein P, Chosidow O, Mahr A, Fardet L. Incidence of and mortality from epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) in France during 2003–16: a four‐source capture–recapture estimate. Br J Dermatol 2019; 182:618-624. [DOI: 10.1111/bjd.18424] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/02/2019] [Indexed: 12/14/2022]
|
28
|
Dhaille F, Dillies A, Dessirier F, Reygagne P, Diouf M, Baltazard T, Lombart F, Hébert V, Chopinaud M, Verneuil L, Becquart C, Delaporte E, Lok C, Chaby G. A single typical trichoscopic feature is predictive of tinea capitis: a prospective multicentre study. Br J Dermatol 2019; 181:1046-1051. [DOI: 10.1111/bjd.17866] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/04/2019] [Indexed: 12/25/2022]
|
29
|
Phan C, Beauchet A, Burztejn A, Severino‐Freire M, Barbarot S, Girard C, Lasek A, Reguiai Z, Hadj‐Rabia S, Abasq C, Brenaut E, Droitcourt C, Perrussel M, Mallet S, Phan A, Lacour J, Khemis A, Bourrat E, Chaby G, Deborde R, Plantin P, Maruani A, Piram M, Maccari F, Fougerousse A, Kupfer‐Bessaguet I, Balguérie X, Barthelemy H, Martin L, Quiles‐Tsimaratos N, Mery‐Brossard L, Pallure V, Lons‐Danic D, Bouilly‐Auvray D, Beylot‐Barry M, Puzenat E, Aubin F, Mahé E. Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis. J Eur Acad Dermatol Venereol 2019; 33:1984-1992. [DOI: 10.1111/jdv.15579] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2018] [Accepted: 02/27/2019] [Indexed: 02/06/2023]
|
30
|
Dairi M, Dadban A, Arnault J, Lok C, Chaby G. Localized mycosis fungoides treated with laser‐assisted photodynamic therapy: a case series. Clin Exp Dermatol 2019; 44:930-932. [DOI: 10.1111/ced.13936] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/08/2018] [Indexed: 12/01/2022]
|
31
|
Dubois C, Dadban A, Denamps J, Arnault JP, Lok C, Chaby G. Congenital melanocytic naevus and congenital strabismus. Clin Exp Dermatol 2019; 44:213-214. [DOI: 10.1111/ced.13622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/27/2017] [Indexed: 11/27/2022]
|
32
|
Lombart F, Dillies A, Senet P, Pourchot D, Oro S, Modiano P, Barete S, Perceau G, Humbert P, Brault F, Poreaux C, Lorriaux A, Lok C, Chaby G. Calciphylaxie chez des patients non insuffisants rénaux : série de 10 cas. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
33
|
Philibert F, Arnault JP, Adjide C, Baltazard T, Dadban A, Chaby G, Lok C. Gestion d’une épidémie d’Acinetobacter baumanii résistant à l’imipénem (ABRI) dans un service de dermatologie. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
34
|
Dairi M, Arnault JP, Dadban A, Lombart F, Attencourt C, Ortonne N, Lok C, Chaby G. Pseudolymphome cutané en forme de nodules sur des plaques de morphée préexistante. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
35
|
Amy de la Breteque M, Beauchet A, Maccari F, Ruer-Mulard M, Bastien M, Chaby G, Le Guyadec T, Estève E, Parier J, Dauendorffer JN, Barthelemy H, Gener G, Wagner L, Pfister P, Bégon E, Mery-Brossard L, Schmutz JL, Mahé E. Les patients psoriasiques vus en cabinet libéral et à l’hôpital sont-ils différents ? Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
36
|
Joachim-Naepels C, Toubeau G, Attencourt C, Chaby G, Petit T. Proposition d’une classification en stades histopronostiques pour l’hidradénite suppurée à partir d’une série de 172 préparations histologiques. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
37
|
Masmoudi W, Hebert V, Quéreux G, Bedane C, Prost-Squarcioni C, Debarbieux S, Oro S, Chaby G, D’incan M, Litrowski N, Boulard C, Roussel A, Kottler D, Abasq C, Richard MA, Duvert-Lehembre S, Gottlieb J, Plantin P, Joly P. Calcul des valeurs seuils du score BPDAI (Bullous Pemphigoid Disease Area Index) définissant les formes légères, modérées et sévères de la pemphigoïde bulleuse. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
38
|
Metzelard M, Chaby G, Schmidt J, Duhaut P, Boulu X, Clement B, Lombart F, Ikoli J, Chatelain D, Baltazard T, Smail A, Salle V. Association psoriasis et syndrome Sjögren-like : quand la pathologie inflammatoire rencontre la pathologie auto-immune, nouvelle entité ou association fortuite ? Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
39
|
Jelti L, Cordel N, Gillibert A, Lacour JP, Uthurriague C, Doutre MS, Delaporte E, Duvert-Lehembre S, Quereux G, Dupuy A, Adamski H, Bedane C, Misery L, Abasq Thomas C, Fleuret C, Bernard P, Chaby G, D’incan M, Verneuil L, Litrowski N, Joly P. Mortalité du pemphigus et facteurs pronostiques, incluant les traitements initialement proposés. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
40
|
Joachim C, Gras-Champel V, Marolleau JP, Chaby G, Dairi M, Carmi E. [Cytopenia under topical imiquimod in two patients treated with oral hydroxyurea]. Ann Dermatol Venereol 2018; 145:765-768. [PMID: 30217687 DOI: 10.1016/j.annder.2018.07.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2017] [Revised: 02/04/2018] [Accepted: 07/30/2018] [Indexed: 11/30/2022]
Abstract
BACKGROUND Aldara® is a topical immunomodulatory treatment. The risks of systemic passage are minimal. There have been rare reports of systemic adverse effects. PATIENTS AND METHODS Case 1. Five sachets weekly of imiquimod were prescribed for Bowen's disease on the forearm in a patient known to have essential thrombocytosis under Hydrea®. His CBC was normal (6000 leukocytes/mm3, 2200 PMN/mm, 230,000 platelets/mm3). Imiquimod was given in 15 sachets weekly. Fifteen day later, the patient presented bicytopenia (3000 leukocytes/mm3, 1400 PMN/mm3, 119,000 platelets/mm3). Hydroxyurea and imiquimod were suspended until normalization of CBC. Hydroxyurea was resumed without recurrence of the bicytopenia. The patient's history included an identical episode following application of imiquimod. Case 2. Five sachets weekly of imiquimod were prescribed for actinic keratosis on the scalp in a patient known to have primary polycythemia under hydroxyurea. Her CBC was normal except for anemia (Hb 11.5g/L, 160,000 platelets/mm3, 1100 lymphocytes/mm3). Imiquimod was given in 12 sachets weekly. Ten days later, anemia increased (Hb 10g/dL) with lymphopenia (800/mm3) and thrombocytopenia (115,000/mm3). Suspension of imiquimod resulted in normalization of the previous CBC values. DISCUSSION . The literature review identified reports of dose-dependent lymphopenia under oral imiquimod but not under Aldara®. The National Pharmacovigilance Database listed 10 cases of hematological disorders most likely caused by Aldara®. Hydroxyurea may induce cytopenia, and while it was not considered the sole causative agent in this case, it is likely to have had a triggering role in these patients with blood dyscrasias. Our findings show that misuse of imiquimod carries a potential risk of hematologic abnormality in patients receiving concomitant hydroxyurea, a commonly combined drug.
Collapse
|
41
|
Chaby G, Valeyrie-Allanore L, Duong TA, Lebrun-Vignes B, Milpied B, Sassolas B, Tetart F, Wolkenstein P, Chosidow O, Fardet L. Severe cutaneous adverse reactions due to inappropriate medication use. Br J Dermatol 2018; 179:329-336. [PMID: 29352771 DOI: 10.1111/bjd.16365] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/02/2018] [Indexed: 11/29/2022]
Abstract
BACKGROUND The proportion of severe cutaneous adverse reactions (SCARs) that could be avoided if medication use was consistent with good medical practice is unknown. OBJECTIVES To estimate the proportion of SCARs related to inappropriate medication use. METHODS We carried out a retrospective study of all validated SCARs collected in a French registry between 2003 and 2016. For each case, all plausible drugs suspected of inducing SCARs (i.e. not just the drug regarded as 'the most probable') were considered with regard to (i) prescription for an inappropriate indication, (ii) unintentional rechallenge despite a previous allergy to the drug or (iii) self-medication with prescription medicines. RESULTS In total, 602 cases were included in the analyses. Antibiotics, anticonvulsants and allopurinol were the drugs most frequently involved, accounting for more than 50% of all cases. All suspected medications were considered to have been appropriately used for 417 of the 602 individuals included in the study population [69·3%, 95% confidence interval (CI) 65·6-73·0] and inappropriately used for 144 individuals (23·9%, 95% CI 20·5-27·3). These inappropriate uses were due mainly to prescriptions for an inappropriate indication (65·8%, 95% CI 58·4-73·2) or unintentional rechallenge (20·9%, 95% CI 14·6-27·2). Allopurinol and co-trimoxazole were the drugs most frequently involved in inappropriate indications. Antibiotics were the largest group involved in unintentional rechallenge. Nonsteroidal anti-inflammatory drugs, available on prescription, were most frequently involved in inappropriate self-medication. CONCLUSIONS Our results underline the need for respecting the appropriate indication for drugs in order to reduce the incidence of SCARs. Reducing unintentional rechallenge also seems to be a necessary preventive measure.
Collapse
|
42
|
Loget J, Saint-Martin C, Guillem P, Kanagaratnam L, Becherel PA, Nassif A, Fougerousse AC, Siham M, Girard C, Barthelemy H, Chaby G, Gabison G, Perrot JL, Pallure V, Beneton N, Boye T, Jacobzone C, Begon E, Bernard P, Reguiai Z. [Misdiagnosis of hidradenitis suppurativa continues to be a major issue. The R-ENS Verneuil study]. Ann Dermatol Venereol 2018; 145:331-338. [PMID: 29704958 DOI: 10.1016/j.annder.2018.01.043] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2017] [Revised: 11/20/2017] [Accepted: 01/19/2018] [Indexed: 11/25/2022]
Abstract
OBJECTIVE To provide physicians with an understanding of the factors behind significant delays in the diagnosis of hidradenitis suppurativa (HS) in France. PATIENTS AND METHODS This prospective multicentre national study conducted from October 2015 to March 2016 included all patients consulting for HS. Patient data were collected by means of a standardized questionnaire. Univariate and multivariate analyses were conducted to collect factors associated with a significant time to diagnosis of at least 5.5years, defined as the period between the onset of initial clinical signs and the time of formal diagnosis. RESULTS The 16 participating centres enrolled 312 patients (62% women), of average age 35years. The average age at onset of HS was 22years. Before formal diagnosis by a dermatologist (64% of cases), 170 (54%), 114 (37%) and 45 (15%) patients had previously consulted at least 3, 5 and 10 general physicians, respectively. The average time between the initial clinical signs of HS, the first dermatology visit and the definitive diagnosis was 6.2 and 8.4 years, respectively. Active smoking (OR adjusted 1.85; P=0.027) and disease onset at a younger age (adjusted OR 0.92; P<0.001) were both associated with significant delays in diagnosis. CONCLUSION These results emphasized misdiagnosis among HS patients but did not evidence any association between either sociodemographic or economic characteristics and the existence of significant times to diagnosis.
Collapse
|
43
|
Lafabregue E, Denamps J, Chaby G, Lok C. Une pustulose exanthématique aiguë localisée (PEAL) palmo-plantaire. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
44
|
Mahé E, Beauchet A, Fougerousse AC, Becherel PA, Begon E, Chaby G, Bravard P, Quiles-Tsimaratos N, Avenel-Audran M, Poiraud C, Mery-Brossard L, Lons-Danic D, Jacobzone C, Pauwels C, Kupfer-Bessaguet I, Amy de la Breteque M, Maccari F, Sigal ML. Influence des caractéristiques des patients sur le choix d’une biothérapie (anti-TNF-alpha vs anti-Il 12/23) pour un psoriasis. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
45
|
Chaby G, Valeyrie-Allanore L, Duong TA, Lebrun-Vignes B, Milpied B, Sassolas B, Tetart F, Wolkenstein P, Chosidow O, Fardet L. Toxidermies sévères liées à une prescription inappropriée des médicaments : étude nationale rétrospective. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
46
|
Plaquevent M, Tetart F, Fardet L, Oro S, Bernard P, Roussel A, Avenel-Audran M, Chaby G, D’incan M, Souteyrand P, Duvert-Lehembre S, Picard-Dahan C, Jeudy G, Labeille B, Morice C, Richard MA, Bourgault Villada I, Litrowski N, Bara C, Mahe E, Prost C, Alexandre M, Quereux G, Soria A, Thomas-Beaulieu D, Pauwels C, Joly P. Pemphigoïdes bulleuses associées aux gliptines : mythe ou réalité ? Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.083] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
47
|
Joachim-Naepels C, Dadban A, Arnault JP, Lorriaux A, Denamps J, Lok C, Chaby G. Mésusage médicamenteux : un cas fatal d’érythème pigmenté fixe bulleux généralisé au paracétamol. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
48
|
Delcroix F, Francois C, Sevestre H, Lok C, Marolleau JP, Chaby G. Étude de la présence et de la signification étiologique d’une réplication cutanée du virus herpès du groupe 6 (HHV6) au cours des exanthèmes en hématologie. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
49
|
Bertrand A, Ofaiche J, Bernard P, Lipsker D, Saillard C, Granel-Brocard F, Jachiet M, Ledard AP, Aubin F, Avenel-Audran M, Chaby G, Jeudy G, Meunier L, Richard MA, Joly P, Guillot B, Dereure O. Place du rituximab dans les pemphigoïdes bulleuse et gestationnelle : étude rétrospective nationale multicentrique de 48 observations. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.088] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
50
|
Baltazard T, Dhaille F, Duvert-Lehembre S, Lok C, Chaby G. Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Dermatol Online J 2017; 23:13030/qt9gv0j00w. [PMID: 29469749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2017] [Accepted: 08/18/2017] [Indexed: 06/08/2023] Open
Abstract
BACKGROUND Linear IgA bullous dermatosis (LABD) is an autoimmune blistering skin disorder characterized by linear IgA deposits along the dermoepidermal junction. Usually idiopathic, LABD can be drug-induced. OBJECTIVE To report the atypical characteristics of a case of trimethoprim-sulfamethoxazole-induced LABD presenting as toxic epidermal necrolysis (TEN). METHODS A 63-year-old woman treated with trimethoprim-sulfamethoxazole for Pneumocystis jirovecii infection developed a generalized maculopapular rash with herpetiform lesions, rosette-like lesions, and tense bullae with Nikolsky sign. RESULTS Anti-basement membrane zone antibodies were negative, but immunoblot revealed a 160 kDa band corresponding to subepidermal class IgA desmoglein 1. Skin biopsy specimens revealed a subepidermal bulla and direct immunofluorescence showed linear IgA deposition along the basement membrane zone. A diagnosis of toxic epidermal necrolysis was excluded and replaced by trimethoprim-sulfamethoxazole-induced LABD. CONCLUSION We report a case of trimethoprim-sulfamethoxazole-induced LABD with a 160 kDa IgA desmoglein 1 found by immunoblotting analysis, probably by epitope spreading.
Collapse
|